BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Liver
,
Personalized medicine
,
Vitamin E
,
rs4950928
,
BRAF
,
Angiogenesis
,
HIV infection
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
13 I
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
Mitochondria-Targeted Triphenylphosphonium Conjugated C-3 Modified Betulin: Synthesis, Antitumor Pro…
Anomalous phenology of Ixodes scapularis (Ixodida: Ixodidae) in Mississippi.
Effectiveness of cognitive-based interventions for improving body image of patients having breast ca…
Fourteen Crutches for Mediocrity. The logismoi that jeopardize good research and publication.
Fourteen Crutches for Mediocrity. The logismoi that jeopardize good research and publication.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Phase I Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine and 14-valent Pneumococcal Co…
Oral Liquid 13-cis-retinoic Acid (13-CRA)
Double Blind Phase III Trial of Effects of Low Dose 13-Cisretinoic Acid on Prevention of Second Prim…
Cabozantinib in Combination With 13-cis-Retinoic Acid in Children With Relapsed or Refractory Solid …
Clinical Tolerance of Numeta 13%
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ